Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hypericin diagnostic and therapeutic - Sanochemia

Drug Profile

Hypericin diagnostic and therapeutic - Sanochemia

Alternative Names: Polyvinylpyrrolidone-hypericin; Povidone-hypericin; PVP-hypericin; SPH-3542; Vidon

Latest Information Update: 31 Jan 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Planta Natural Products
  • Developer Austrian Academy of Sciences; Sanochemia Pharmazeutika
  • Class Anthraquinones; Anti-inflammatories; Antidepressants; Antipsoriatics; Antivirals; Cytostatics; Perylenes; Polycyclic compounds; Radiation-sensitising agents; Small molecules
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Bladder cancer

Most Recent Events

  • 31 Jan 2018 PVP-hypericin is still in preclinical development for Bladder cancer in Austria (Sanochemia Pharmazeutika pipeline, January 2018)
  • 25 Jan 2018 PVP-hypericin licensed to Newfield Therapeutics in USA, Canada, Australia and certain parts of Asia
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Bladder-cancer in Austria (Intravesicular, Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top